Junior Manager Quality Control at Acadia Pharmaceuticals

Kiel, Schleswig-Holstein, Germany

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Completed degree in Biology with a focus on Microbiology or several years of professional experience in pharmaceutical microbiology
PhD in Biology desirable
Professional experience, preferably in the pharmaceutical industry or comparable environment with a microbiological focus
Ideally, experience in microbiological processes for maintaining aseptic workflows; first experience in pharmaceutical manufacturing of DPD desirable
Ideally, initial experience in project management
Sound knowledge of GMP-compliant documentation
Good English skills in spoken and written
Convincing and assertive, with high self-motivation and willingness to take responsibility
Resilient and enjoys working in a performance-oriented environment
Problem-solving oriented and confident in handling conflict situations
Structured and goal-oriented working style, team-capable and communicative personality
Proficient in common MS Office programs
Enjoys interacting with people and achieving success as a team

Responsibilities

Conducting and planning microbiological quality control according to national and international GMP guidelines and GMP-compliant documentation of results in the team
Performing root cause analyses and risk assessments for microbiological deviations and contributing to CAPA management
Reviewing and microbiologically evaluating test results
Supporting and contributing to continuous process improvement: developing microbiological trend analyses, maintaining microbiological methods, developing test specifications, in interdisciplinary projects (e.g., introduction of new products/methods), and in inspection preparations
Professional supervision of lab assistants (e.g., training) and coordination of workflows in microbiology (e.g., prioritization)
Passing on information (e.g., from projects and planning meetings) to the team
Supporting microbiological issues and improvements in aseptic manufacturing processes and aseptic process simulation (APS)

Skills

GMP

Mikrobiologische Qualitätskontrolle

Ursachenanalysen

Risikobewertungen

CAPA-Management

Trendanalysen

Mikrobiologische Methoden

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters

1993Year Founded

$813.4MTotal Funding

ACQUISITIONCompany Stage

Biotechnology, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.

Potential clinical trial delays could affect drug approval timelines.

Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.

The company has a strong R&D foundation, developing innovative small molecule drugs.

Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.

Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.

The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI

Try Jobo Free